Details.
A study of a potential new medicine, given as a gel, to treat chemotherapy induced peripheral neuropathy. For male or female participants aged 18 to 80 who have received chemotherapy treatment for cancer, are in remission and have had CIPN for at least 3 months. Participation involves up to 6 outpatient clinic visits, including 3 optional skin biopsies, and 1 telephone follow-up. Study payment is up to £2,380.
